Stryker Corp., US8636671013

Stryker stock: Leerink and BTIG raise targets

Published on 11/21/2026 at 11:40 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Stryker stock gained analyst support as Leerink and BTIG lifted their targets during the week. Management defended its long-term growth framework.

Analyst support meets recovery focus

  • BTIG and Leerink raised their Stryker targets while retaining positive ratings.
  • Management reaffirmed its long-term growth framework amid cyber disruption and softer orthopedic demand.
  • The incoming chief executive is expected to prioritize growth, specialization and simpler operations.
Stryker Corp., US8636671013, Illustration mit AI erstellt.

Stryker stock was in focus during the week ended Friday, November 20, after two investment banks raised their price targets. BTIG lifted its target on Wednesday, November 18, while Leerink followed on Thursday, November 19. Both firms retained positive ratings, according to Markets Insider and Markets Insider.

Analysts raise their targets

BTIG raised its Stryker target from 304 US dollars to 345 US dollars and kept a Buy rating. The firm said it was updating its medical-technology models after the company's third-quarter results.

Leerink raised its target from 340 US dollars to 356 US dollars and maintained an Outperform rating. The firm cited stronger conviction that medical technology could deliver outsized returns over the next 12 to 24 months.

Management holds its framework

At the Jefferies Global Healthcare Conference on Tuesday, November 17, management reiterated its long-term growth framework, according to Investing.com. The plan calls for high-end market growth, 150 basis points of adjusted operating-margin expansion over three years and annual free-cash-flow conversion of 70% to 80%.

Incoming chief executive Spencer Stiles, who is scheduled to take over in January 2027, identified faster growth, deeper specialization and a simpler operating model as early priorities. The discussion also covered cyber disruption, softer orthopedic demand and the company's robotics relationship with CMR Surgical.

Saturday trading snapshot

Stryker stock traded at 282.65 euros on Lang & Schwarz at 11:37 CET on Saturday, November 21.

Stryker Corporation stock facts

  • Company: Stryker Corporation
  • ISIN: US8636671013
  • Ticker: SYK.DE
  • Lang & Schwarz quote: 282.65 euros on Saturday, November 21, 2026, at 11:37 CET
  • Xetra close: 285.50 euros on Tuesday, November 17, 2026

Investors can follow broader market developments in Current market reports.

More news and analyses on Stryker stock.

Disclaimer...
en | US8636671013 | STRYKER CORP. | boerse | 70542173 | bgmi